how long have glp 1 drugs been on the market GLP-1 Drug Market: rapid growth of the diabetes and obesity GLP-1 Receptor Agonists Obesity Drugs
Description
R., Han J., et al., Effects of Exenatide (Exendin4) on Glycemic Control Over 30 Weeks in SulfonylureaTreated Patients With Type 2 Diabetes, Diabetes Care 27 (2004): 26282635
Morgan Stanley Investment Management
In contrast, Wegovy and semaglutide-based alternatives affect only GLP-1 pathways
Injecting the same square inch of skin repeatedly can cause lipohypertrophy, a condition where fatty tissue becomes lumpy or hard
Injectable semaglutide also has a higher bioavailability, meaning your body absorbs a smaller dose of the medication well
